跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AURO-CANDESARTAN HCT 16/12.5 candesartan cilexetil/hydrochlorothiazide 16 mg/12.5 mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
AURO-CANDESARTAN HCT 16/12.5 candesartan cilexetil/hydrochlorothiazide 16 mg/12.5 mg tablet blister pack
Approved
STANDARD
AURO-CANDESARTAN HCT 16/12.5 candesartan cilexetil/hydrochlorothiazide 16 mg/12.5 mg tablet blister pack
Strides Pharma Science Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 28, 2025
Approval ID
fd378710ba9b0490
Company
Strides Pharma Science Pty Ltd
Type
Standard
Approval Details
Approval Id
fd378710ba9b0490
Product Name
AURO-CANDESARTAN HCT 16/12.5 candesartan cilexetil/hydrochlorothiazide 16 mg/12.5 mg tablet blister pack
Artg Id
199106
Artg Name
AURO-CANDESARTAN HCT 16/12.5 candesartan cilexetil/hydrochlorothiazide 16 mg/12.5 mg tablet blister pack
Sponsor
Strides Pharma Science Pty Ltd
Company Detail Path
/organization/strides-pharma-science-pty-ltd
Artg Date
2013-12-18
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 28, 2025
Approval ID
fd378710ba9b0490
Type
Standard
Back to TGA Approvals